Branded

VALLEY FORGE, Pa. — AmerisourceBergen posted double-digit gains in second quarter revenue, reflecting a gain in both the AmerisourceBergen Drug Corp. and the AmerisourceBergen Specialty Group.

Revenue for the second quarter ended March 31 totaled $28.5 billion, up 38.6% compared with the year-ago period.

WOONSOCKET, R.I. — CVS/pharmacy is teaming up with The Partnership at Drugree.org to create a community donation program through which local police departments can apply to receive a drug collection unit to help their communities safely dispose of unwanted medications, including controlled substances, the pharmacy retailer announced on Thursday.

DUBLIN — Endo International announced that its affiliates have acquired rights to Sumavel DosePro (sumatriptan injection) for subcutaneous use from Zogenix. The product is a needle-free delivery system for sumatriptan. Sumavel DosePro is used to treat adults who have been diagnosed with acute migraine or cluster headaches.

NEW YORK — Cefaly Technology announced Wednesday that the Cefaly medical device for the preventive treatment of migraine headaches is available for purchase and delivery in the United States for patients with a medical prescription at Cefaly.us.

The company that manufactures Cefaly expects to make the device available via select pharmacies and clinics in the months ahead. 

IRVINE, Calif. — Allergan on Tuesday confirmed that it has received an unsolicited proposal from Valeant Pharmaceuticals to acquire all of the outstanding shares of the company for a combination of 0.83 of Valeant common shares and $48.30 in cash per share of common stock of Allergan.

ZURICH — Novartis on Tuesday made a number of moves that have fundamentally reshaped its business, according to published reports. Novartis exchanged its vaccine business with GlaxoSmithKline in a deal valued at $7.1 billion for GSK's oncology portfolio (at a cost of $14.5 billion) and divested its animal health unit to Ely Lilly for approximately $5.4 billion. 

ARLINGTON, Va. — This week, 49 members of the U.S. House of Representatives urged Health and Human Services Secretary Kathleen Sebelius to adopt a one-year transition period for states to implement the July 2014 average manufacturer price-based federal upper limits. The National Association of Chain Drug Stores commended Reps. Mike Rogers, R-Mich., and Bruce Braley, D-Iowa, for leading the letter effort with their colleagues.

LONDON — Pfizer is making a bid of $100.8 billion (£60 billion) for Astra Zeneca, according to a report in the Sunday Times, a U.K. daily, published Sunday. 

Citing insiders, the Sunday Times reported that, internally, Astra Zeneca is resisting the overture. 

"The New York company is keen to deploy a $70 billion (£42 billion) cash pile that it has accumulated in overseas subsidiaries," the paper reported.